These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1885064)

  • 1. Serum pepsinogen I concentrations in peptic ulcer patients in relation to ulcer location and stage.
    Tanaka Y; Mine K; Nakai Y; Mishima N; Nakagawa T
    Gut; 1991 Aug; 32(8):849-52. PubMed ID: 1885064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
    Samloff IM; Liebman WM; Panitch NM
    Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pepsin concentration in gastroduodenal biopsy homogenates in chronic ulcer disease.
    Vianello F; Di Mario F; Plebani M; Germana B; Dal Santo P; Leandro G; Dotto P; Grassi SA; Battaglia G; Naccarato R
    Dig Dis Sci; 1994 Feb; 39(2):301-8. PubMed ID: 8313812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pepsinogen Group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients.
    Plebani M; Di Mario F; Vianello F; Giordano A; Masiero M; Lazzaretto M; Farini R; Ceriotti G; Naccarato R
    Clin Biochem; 1983 Feb; 16(1):20-2. PubMed ID: 6861334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum group I pepsinogen (PG I) levels and their changes in the healing process of the ulcer in patients with and without unoperated recurrent ulcer.
    Nakanome C; Yamazaki H; Tanno N; Sasaki M; Sato W; Hanada M; Moriai N; Komatsu K
    Tohoku J Exp Med; 1984 Jun; 143(2):239-48. PubMed ID: 6474453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.
    Samloff IM; Stemmermann GN; Heilbrun LK; Nomura A
    Gastroenterology; 1986 Mar; 90(3):570-6. PubMed ID: 3943688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pepsinogen: correlation of techniques and analysis of levels found in different diseases of the stomach and duodenum.
    Sáez-Alquézar A; Marchese MA; Bezerra TV; Andreoli JC; Parra DS; Pontes JF
    Clin Chim Acta; 1978 Dec; 90(2):163-9. PubMed ID: 719900
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of pepsinogen group I in endoscopic gastroduodenal biopsies.
    Plebani M; Di Mario F; Dal Santo PL; Faggian D; Germana B; Vianello F; Naccarato R; Burlina A
    Clin Chem; 1990 Apr; 36(4):682-4. PubMed ID: 2323049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
    Wu MS; Wang HP; Wang JT; Wang TH; Lin JT
    J Gastroenterol Hepatol; 1995; 10(4):401-4. PubMed ID: 8527705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?].
    De Lazzari F; Venturi C; Fregona I; Galliani EA; Bortolami M; Violato D; Floreani AR; Plebani M; Naccarato R
    Minerva Gastroenterol Dietol; 1994 Mar; 40(1):1-9. PubMed ID: 8204699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical investigation of serum group I pepsinogen (PG I) by radioimmunoassay].
    Nakanome C; Akai H; Goto Y
    Nihon Shokakibyo Gakkai Zasshi; 1982 Aug; 79(8):1568-75. PubMed ID: 7176148
    [No Abstract]   [Full Text] [Related]  

  • 12. Pepsinogen C gene polymorphisms associated with gastric body ulcer.
    Azuma T; Teramae N; Hayakumo T; Yasuda K; Nakajima M; Kodama T; Inokuchi H; Hayashi K; Taggart RT; Kawai K
    Gut; 1993 Apr; 34(4):450-5. PubMed ID: 8098309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pepsinogen values as possible markers for evaluating the possibility of peptic ulcer recurrence under H2-blocker half-dose maintenance therapy.
    Matsushima M; Miki K; Ichinose M; Kakei N; Yahagi N; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
    Adv Exp Med Biol; 1995; 362():131-7. PubMed ID: 8540311
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum pepsinogen I levels of gastric ulcer patients are determined by the location of the ulcer crater.
    Chang FY; Lai KH; Wang TF; Lee FY; Lee SD; Tsai YT
    Gastroenterol Jpn; 1992 Feb; 27(1):9-14. PubMed ID: 1555752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion.
    Samloff IM; Secrist DM; Passaro E
    Gastroenterology; 1975 Dec; 69(6):1196-200. PubMed ID: 1193320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
    Matsukawa Y; Nishinarita S; Kaneko M; Takei M; Murakami M; Horie T; Kawamura F; Arakawa Y; Kuwayama H; Kurosaka H
    Int J Clin Pharmacol Res; 1997; 17(4):127-32. PubMed ID: 9526173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.
    Ichinose M; Miki K; Furihata C; Kageyama T; Hayashi R; Niwa H; Oka H; Matsushima T; Takahashi K
    Clin Chim Acta; 1982 Dec; 126(2):183-91. PubMed ID: 7151278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum group I pepsinogen levels in patients with peptic ulcer and normal subjects.
    Nakanome C; Akai H; Goto Y
    Tohoku J Exp Med; 1983 Feb; 139(2):151-8. PubMed ID: 6404006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of serum group I pepsinogen level in gastric duodenal diseases].
    Noguchi M; Nakajima K; Yoshii M; Kono S; Aoki E; Tanaka K; Adachi H; Torizuka K
    Nihon Shokakibyo Gakkai Zasshi; 1983 Feb; 80(2):131-9. PubMed ID: 6865060
    [No Abstract]   [Full Text] [Related]  

  • 20. Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use.
    Janssen M; Dijkmans BA; Vandenbroucke JP; Biemond I; Lamers CB
    Dig Dis Sci; 1994 Feb; 39(2):362-5. PubMed ID: 8313819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.